ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01414829
Recruitment Status : Withdrawn (difficulty in recruiting parients)
First Posted : August 11, 2011
Last Update Posted : December 4, 2012
Sponsor:
Information provided by:
The Baruch Padeh Medical Center, Poriya

Brief Summary:
Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture.

Condition or disease Intervention/treatment
Other Diseases or Conditions | Patient Procedure: Gastroscopy

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment and Comparing of Different Methods for Helicobacter Pylori Disclosure
Study Start Date : August 2011
Estimated Primary Completion Date : January 2012
Study Completion Date : January 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antibiotics Biopsy


Intervention Details:
  • Procedure: Gastroscopy
    The reason for gastroscopy will be not related to the study


Biospecimen Retention:   Samples Without DNA
gastric biopsies


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   10 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patient referred for gastroscopy because of clinical reasons
Criteria

Inclusion Criteria:

  • all referred for gastroscopy with clinical or endoscopic signs of peptic disease

Exclusion Criteria:

  • coagulation disorders
  • pregnant women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01414829


Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Principal Investigator: Maya PAritsky, MD Baruch Padeh MC, Israel

Responsible Party: Paritsky Maya, Baruch Padeh MC
ClinicalTrials.gov Identifier: NCT01414829     History of Changes
Other Study ID Numbers: paritsky1.ct.il
First Posted: August 11, 2011    Key Record Dates
Last Update Posted: December 4, 2012
Last Verified: December 2012

Keywords provided by The Baruch Padeh Medical Center, Poriya:
Peptic disease
Helicobacter pylori
Different methods

Additional relevant MeSH terms:
Anti-Bacterial Agents
Anti-Infective Agents